Parasitology · 1993 · 40 citations · 33 references
MedicineMedicinal ChemistryPharmacologyBiochemical PharmacologyChemotherapyPharmacodynamicsEnzyme InhibitionMalariaAntimalarial AgentsAntimalarial ChemotherapyAntimalarial Drug DevelopmentChemotherapy Of MalariaMalaria ParasitesMalaria ProphylaxisProphylactic TreatmentSporozoite Stage
The causal prophylactic activity of the novel hydroxynaphthoquinone, 566C80, was assessed against the exo-erythrocytic (EE) stages of Plasmodium berghei cultured in the human hepatoma cell line, HepG2. 566C80 was found to be highly active as an inhibitor of EE development and was more active than the established causal prophylactic pyrimethamine. A 566C80 concentration of 1.85 x 10(-9) M, added 3 h after sporozoite invasion, reduced the numbers of EE forms visible at 48 h by 50 degrees o, while the equivalent concentration of pyrimethamine was 1.95 x 10(-8) M.
33
Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity
Alan T. Hudson, Amy Randall, M. Fry et al. · Parasitology · 1985 · 191 citations
Complete Development of Hepatic Stages of <i>Plasmodium falciparum</i> in Vitro
Dominique Mazier, Richard L. Beaudoin, S Mellouk et al. · Science · 1985 · 170 citations
Chemotherapy of Malaria and Resistance to Antimalarials.
Annals of Internal Medicine · 1974 · 142 citations